Susquehanna Fundamental Investments, LLC Astrazeneca PLC Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $14.9 Million - $17.6 Million	-276,112 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $15.3 Million - $16.8 Million	276,112 New	276,112 $16.6 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $2.34 Million - $3.18 Million	-62,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $454,322 - $539,922	10,700 Added 20.86%	62,000 $3.09 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $2.3 Million - $2.61 Million	-57,418 Reduced 52.81%	51,300 $2.29 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $2.11 Million - $2.55 Million	59,318 Added 120.08%	108,718 $4.4 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $1.39 Million - $1.56 Million	-37,600 Reduced 43.22%	49,400 $1.88 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $2.87 Million - $3.19 Million	87,000 New	87,000 $3.04 Million

1,334

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.